Relationship between inhibition of prostaglandin beta-oxidation and deenergization of mitochondrial membranes.
D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D007099:Imipramine / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism*; D008933:Mitochondrial Swelling / Q000187:drug effects; D010084:Oxidation-Reduction; D010085:Oxidative Phosphorylation / Q000187:drug effects; D011458:Prostaglandins E / Q000378:metabolism*; D051381:Rats; D012459:Salicylates / Q000494:pharmacology
D004140:Dinitrophenols; D011458:Prostaglandins E; D012459:Salicylates; D002258:Carbonyl Cyanide m-Chlorophenyl Hydrazone; D007099:Imipramine; D001241:Aspirin; D002746:Chlorpromazine; D007213:Indomethacin